M

Mabion SA
WSE:MAB

Watchlist Manager
Mabion SA
WSE:MAB
Watchlist
Price: 11.4 PLN -0.87% Market Closed
Market Cap: 184.3m PLN
Have any thoughts about
Mabion SA?
Write Note

Intrinsic Value

MAB's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MAB stock under the Base Case scenario is 16.19 PLN. Compared to the current market price of 11.4 PLN, Mabion SA is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MAB Intrinsic Value
16.19 PLN
Undervaluation 30%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
Mabion SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MAB?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Mabion SA

Provide an overview of the primary business activities
of Mabion SA.

What unique competitive advantages
does Mabion SA hold over its rivals?

What risks and challenges
does Mabion SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mabion SA.

Provide P/S
for Mabion SA.

Provide P/E
for Mabion SA.

Provide P/OCF
for Mabion SA.

Provide P/FCFE
for Mabion SA.

Provide P/B
for Mabion SA.

Provide EV/S
for Mabion SA.

Provide EV/GP
for Mabion SA.

Provide EV/EBITDA
for Mabion SA.

Provide EV/EBIT
for Mabion SA.

Provide EV/OCF
for Mabion SA.

Provide EV/FCFF
for Mabion SA.

Provide EV/IC
for Mabion SA.

Show me price targets
for Mabion SA made by professional analysts.

What are the Revenue projections
for Mabion SA?

How accurate were the past Revenue estimates
for Mabion SA?

What are the Net Income projections
for Mabion SA?

How accurate were the past Net Income estimates
for Mabion SA?

What are the EPS projections
for Mabion SA?

How accurate were the past EPS estimates
for Mabion SA?

What are the EBIT projections
for Mabion SA?

How accurate were the past EBIT estimates
for Mabion SA?

Compare the revenue forecasts
for Mabion SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mabion SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mabion SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mabion SA compared to its peers.

Compare the P/E ratios
of Mabion SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Mabion SA with its peers.

Analyze the financial leverage
of Mabion SA compared to its main competitors.

Show all profitability ratios
for Mabion SA.

Provide ROE
for Mabion SA.

Provide ROA
for Mabion SA.

Provide ROIC
for Mabion SA.

Provide ROCE
for Mabion SA.

Provide Gross Margin
for Mabion SA.

Provide Operating Margin
for Mabion SA.

Provide Net Margin
for Mabion SA.

Provide FCF Margin
for Mabion SA.

Show all solvency ratios
for Mabion SA.

Provide D/E Ratio
for Mabion SA.

Provide D/A Ratio
for Mabion SA.

Provide Interest Coverage Ratio
for Mabion SA.

Provide Altman Z-Score Ratio
for Mabion SA.

Provide Quick Ratio
for Mabion SA.

Provide Current Ratio
for Mabion SA.

Provide Cash Ratio
for Mabion SA.

What is the historical Revenue growth
over the last 5 years for Mabion SA?

What is the historical Net Income growth
over the last 5 years for Mabion SA?

What is the current Free Cash Flow
of Mabion SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mabion SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mabion SA

Current Assets 75.1m
Cash & Short-Term Investments 50.2m
Receivables 14.4m
Other Current Assets 10.4m
Non-Current Assets 121.3m
PP&E 115.9m
Intangibles 366k
Other Non-Current Assets 5m
Current Liabilities 41.2m
Accounts Payable 2.4m
Accrued Liabilities 3.3m
Other Current Liabilities 35.4m
Non-Current Liabilities 9.5m
Long-Term Debt 2.3m
Other Non-Current Liabilities 7.2m
Efficiency

Earnings Waterfall
Mabion SA

Revenue
139.9m PLN
Cost of Revenue
-30.4m PLN
Gross Profit
109.5m PLN
Operating Expenses
-52.5m PLN
Operating Income
57m PLN
Other Expenses
-19.6m PLN
Net Income
37.4m PLN

Free Cash Flow Analysis
Mabion SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MAB Profitability Score
Profitability Due Diligence

Mabion SA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
54/100
Profitability
Score

Mabion SA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

MAB Solvency Score
Solvency Due Diligence

Mabion SA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Long-Term Solvency
78/100
Solvency
Score

Mabion SA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MAB Price Targets Summary
Mabion SA

Wall Street analysts forecast MAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAB is 15.81 PLN with a low forecast of 13.13 PLN and a high forecast of 19.43 PLN.

Lowest
Price Target
13.13 PLN
15% Upside
Average
Price Target
15.81 PLN
39% Upside
Highest
Price Target
19.43 PLN
70% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MAB?

Click here to dive deeper.

Dividends

Mabion SA
does not pay dividends
Shareholder Yield

Current shareholder yield for MAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Mabion SA

Country

Poland

Industry

Biotechnology

Market Cap

184.3m PLN

Dividend Yield

0%

Description

Mabion SA is a biotechnology company, which engages in the development and manufacture of biotech drugs. The company is headquartered in Konstantynow Lodzki, Woj. Lodzkie and currently employs 213 full-time employees. The company went IPO on 2010-08-10. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in biotechnology field, including BioCentrum Ltd and Biotech Consulting Ltd. The firm specializes in the humanized monoclonal antibodies (mAbs) technology, a new generation of biotechnological drugs. The company focuses on oncology drugs used to treat blood cancer, lymphomas and leukemias, rheumatoid arthrisis, as well as breast cancer. The company operates its own Research and Development Center in the Special Economical Zone in Lodz, Poland.

Contact

WOJ. LODZKIE
Konstantynow Lodzki
Kompleks Naukowo-Przemyslowy Biotechnologii Medycznej, ul. gen. Mariana Langiewicza 60
+48422077890.0
www.mabion.eu

IPO

2010-08-10

Employees

213

Officers

CEO & President of Management Board
Mr. Krzysztof Kaczmarczyk
CFO, Financial Director & Member of Management Board
Mr. Grzegorz Grabowicz
Member of the Management Board & Scientific and Quality Director
Dr. Slawomir Jaros EMBA, Eng., Ph.D.
Member of Management Board & Business Development Director
Mr. Adam Pietruszkiewicz
Member of the Management Board, Operations Director & COO
Ms. Julita Balcerek M.D.
Chief Accountant
Aneta Turek
Show More
Head of Logistics & Procurement
Pawel Pobiedzinski
Head of Microbiology Laboratory
Joanna Krolasik
Show Less

See Also

Discover More
What is the Intrinsic Value of one MAB stock?

The intrinsic value of one MAB stock under the Base Case scenario is 16.19 PLN.

Is MAB stock undervalued or overvalued?

Compared to the current market price of 11.4 PLN, Mabion SA is Undervalued by 30%.

Back to Top